Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      CDSCO tightens safety and labelling rules for ISOTRETINOIN,prescription of dermatologist mandatory

      CDSCO tightens safety and labelling rules for ISOTRETINOIN,prescription of dermatologist mandatory

      Farhat Nasim21 Dec 2018 1:06 PM IST
      In light of concerns raised regarding Isotretinoin, the matter has been examined by CDSCO in consultation with the Subject Expert Committee...
      Seperate Bills for Hospital Services, Medicines: Proposal with GST Council

      Seperate Bills for Hospital Services, Medicines: Proposal with GST Council

      Farhat Nasim21 Dec 2018 11:40 AM IST
      New Delhi: The Goods and Services Tax (GST) council is all set to give a dose of tax by demanding to unbundle the bills raised by healthcare delivery...
      3.36% of about 82,600 drugs samples found to be substandard

      3.36% of about 82,600 drugs samples found to be substandard

      Farhat Nasim21 Dec 2018 10:00 AM IST
      Of the total, 236 drugs samples or 0.28 per cent were declared spurious or adulterated, Minister of State Chemicals and Fertilisers Mansukh L...
      Strides to get approx Rs 2.95 billion after Mylans claims over Agila sale get rejected

      Strides to get approx Rs 2.95 billion after Mylan's claims over Agila sale get rejected

      Farhat Nasim21 Dec 2018 9:31 AM IST
      Strides Pharma Science and its wholly-owned subsidiary completed the sale to Mylan Laboratories and Mylan Institutional of Agila Specialties Private...
      Yes Bank sells over 2% stake in Fortis Healthcare

      Yes Bank sells over 2% stake in Fortis Healthcare

      Farhat Nasim20 Dec 2018 5:39 PM IST
      Yes Bank sold 1.23 crore equity shares having nominal value of Rs 10 each, constituting 2.13% of the paid-up share capital of Fortis HealthcareNew...
      Religare files criminal complaint against promoters Singh brothers

      Religare files criminal complaint against promoters Singh brothers

      Farhat Nasim20 Dec 2018 10:42 AM IST
      The complaint also names REL ex-CMD Sunil Godhwani, among other directors, for cheating, fraud and misappropriation of funds to the tune of Rs 740...
      GSK, Pfizer to Merge Consumer Healthcare units

      GSK, Pfizer to Merge Consumer Healthcare units

      Farhat Nasim20 Dec 2018 9:29 AM IST
      The deal paves the way for British group GSK to have two UK-listed companies, one specialised in the development of drugs and the other in consumer...
      Mankind Pharma faces setback: Government prohibits Buclizine as Apetite Stimulant

      Mankind Pharma faces setback: Government prohibits Buclizine as Apetite Stimulant

      Farhat Nasim19 Dec 2018 5:34 PM IST
      This came after the Central Government was satisfied that the use of said drug Buclizine does not have any therapeutic value claimed for as an...
      No online sale of drugs till regulatory rules in place: Delhi High Court

      No online sale of drugs till regulatory rules in place: Delhi High Court

      Farhat Nasim19 Dec 2018 10:33 AM IST
      The observations by the bench were made while hearing the applications moved by some online pharmacies seeking to be impleaded in the matter.New...
      IHH unable to proceed with Fortis open offer after SC status quo on deal

      IHH unable to proceed with Fortis open offer after SC status quo on deal

      Farhat Nasim19 Dec 2018 9:35 AM IST
      The open offer by Fortis for an additional 26 per cent stake was scheduled to commence on December 18 and close on January 1, 2019, entailing a total...
      Glenmark Pharma gets USFDA nod for Fluocinolone Acetonide Oil

      Glenmark Pharma gets USFDA nod for Fluocinolone Acetonide Oil

      Farhat Nasim19 Dec 2018 9:15 AM IST
      Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for...
      Merck strengthens animal health unit with $2.4 billion Antelliq purchase

      Merck strengthens animal health unit with $2.4 billion Antelliq purchase

      Farhat Nasim19 Dec 2018 9:00 AM IST
      The move affirms Merck's commitment to the business, which Wall Street analysts have long seen value in separating just as rival drugmakers Eli Lilly...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok